Kuros Biosciences AG (LON:0RHR)
London · Delayed Price · Currency is GBP · Price in CHF 28.00
+0.17 (0.60%)
Dec 17, 2025, 4:06 PM BST
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.02 billion as of December 17, 2025. Its market cap has increased by 37.53% in one year.
Market Cap
1.02B
Enterprise Value
1.01B
Revenue
94.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.00
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 2.27B to 1.02B, a decrease of -54.81%. That is a compound annual growth rate of -7.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 1.02B | 44.26% |
| Dec 30, 2024 | 709.81M | 493.45% |
| Dec 29, 2023 | 119.61M | 148.06% |
| Dec 30, 2022 | 48.22M | -5.76% |
| Dec 30, 2021 | 51.17M | -7.21% |
| Dec 30, 2020 | 55.14M | 27.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 211.08B |
| GSK plc | 73.62B |
| Haleon | 32.86B |
| Smith & Nephew | 10.24B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.33B |
| HUTCHMED (China) | 1.73B |
| Genus | 1.71B |